Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Med Res Opin ; 32(11): 1821-1826, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27404053

RESUMO

OBJECTIVE: To compare the clinical acceptability of micronized purified flavonoid fraction (MPFF) 1000 mg with MPFF 500 mg tablets, administered at the same daily dose in patients suffering non-complicated acute hemorrhoids. BACKGROUND: MPFF is an established treatment for hemorrhoidal disease. METHODS: This was a double-blind, multi-center, randomized study. Patients took either MPFF 1000 mg or 500 mg tablets for 7 days (daily dose; 3 g over 4 days followed by 2 g over 3 days). Adverse events were recorded in a patient diary. On day 7, anal pain and bleeding were assessed (visual analog scale [VAS] and Dimitroulopoulos scale, respectively). RESULTS: Patients (162) were randomized to MPFF 1000 mg (79) and MPFF 500 mg (83). No serious adverse events (AEs) occurred; 10 emergent AEs were considered treatment-related (6 for MPFF 1000 mg and 4 for 500 mg). Both regimens were associated with significant reduction in anal pain (VAS); -2.37 cm MPFF 1000 mg (P < 0.001) and -2.17 cm 500 mg (P < 0.001), with a slight trend in favor of MPFF 1000 mg (mean global reduction -2.27 cm, P < 0.001). Bleeding improved significantly in both groups of patients, 56% of patients on MPFF 1000 mg versus 61% on MPFF 500 mg. Bleeding ceased after treatment in 47% patients on MPFF 1000 mg versus 54% on 500 mg. CONCLUSION: After 7 days of treatment with MPFF at the same daily dose, both regimens reduced anal pain and bleeding. MPFF 1000 mg had a comparable safety profile to MPFF 500 mg, with the advantage of fewer tablets. Key limitations: Safety study.


Assuntos
Flavonoides/uso terapêutico , Hemorroidas/tratamento farmacológico , Doença Aguda , Adolescente , Adulto , Idoso , Método Duplo-Cego , Feminino , Flavonoides/administração & dosagem , Hemorragia/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Comprimidos
2.
Mol Gen Mikrobiol Virusol ; (1): 15-21, 2014.
Artigo em Russo | MEDLINE | ID: mdl-24757838

RESUMO

The impact of the 8 most common bivalent metal cations (Mg2+, Mn2+, Co2+, Cd2+, Zn2+, Ni2+, Ca2+, Cu2+) on the operation of the whole complex of DNA polymerases in mice brain cell extracts was tested. A decrease in the fidelity of the DNA synthesis was observed in the presence of several metals; among them, Mn2+ caused the most significant effect. It was also demonstrated that this effect was mainly due to the DNA polymerase iota (Pol iota) activity. It is well known that occupational or environmental exposure to excessive Mn could lead to development of neurodegenerative diseases (e.g., manganism). However, the molecular mechanism underlying these pathologies is still unknown. Our results suggest that the neurotoxic effect of Mn2+ may be associated with local activation of highly error-prone Pol iota that increases incorrect DNA synthesis at elevated concentrations of this metal.


Assuntos
Replicação do DNA/efeitos dos fármacos , Manganês/farmacologia , Animais , DNA Polimerase Dirigida por DNA/metabolismo , Manganês/toxicidade , Intoxicação por Manganês/etiologia , Camundongos , DNA Polimerase iota
3.
Biochemistry (Mosc) ; 78(10): 1137-45, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24237148

RESUMO

Bivalent metal cations are key components in the reaction of DNA synthesis. They are necessary for all DNA polymerases, being involved as cofactors in catalytic mechanisms of nucleotide polymerization. It is also known that in the presence of Mn2+ the accuracy of DNA synthesis is considerably decreased. The findings of this work show that Cd2+ and Zn2+ selectively inhibit the Mn2+-induced error-prone DNA polymerase activity in extracts of cells from human and mouse tissues. Moreover, these cations in low concentrations also can efficiently inhibit the activity of homogeneous preparations of DNA polymerase iota (Pol ι), which is mainly responsible for the Mn2+-induced error-prone DNA polymerase activity in cell extracts. Using a primary culture of granular cells from postnatal rat cerebellum, we show that low concentrations of Cd2+ significantly increase cell survival in the presence of toxic Mn2+ doses. Thus, we have shown that in some cases low concentrations of Cd2+ can display a positive influence on cells, whereas it is widely acknowledged that this metal is not a necessary microelement and is toxic for organisms.


Assuntos
Cádmio/farmacologia , Replicação do DNA/efeitos dos fármacos , DNA Polimerase Dirigida por DNA/metabolismo , DNA/biossíntese , Manganês/farmacologia , Inibidores da Síntese de Ácido Nucleico/farmacologia , Zinco/farmacologia , Animais , Biocatálise/efeitos dos fármacos , Encéfalo/enzimologia , Cádmio/metabolismo , Morte Celular/efeitos dos fármacos , Células Cultivadas , Reparo do DNA/efeitos dos fármacos , Relação Dose-Resposta a Droga , Humanos , Fígado/enzimologia , Manganês/metabolismo , Melanoma/enzimologia , Camundongos , Inibidores da Síntese de Ácido Nucleico/metabolismo , Ratos , Ratos Wistar , Relação Estrutura-Atividade , Neoplasias Uveais/enzimologia , Zinco/metabolismo , DNA Polimerase iota
4.
Mol Gen Mikrobiol Virusol ; (1): 14-20, 2013.
Artigo em Russo | MEDLINE | ID: mdl-23785785

RESUMO

The DNA polymerase iota (Pol iota), which has some peculiar features and is characterized by an extremely error-prone DNA synthesis, belongs to the group of enzymes preferentially activated by Mn2+ instead of Mg2+. In this work, the effect of Mn2+ on DNA synthesis in cell extracts from a) normal human and murine tissues, b) human tumor (uveal melanoma), and c) cultured human tumor cell lines SKOV-3 and HL-60 was tested. Each group displayed characteristic features of Mn-dependent DNA synthesis. The changes in the Mn-dependent DNA synthesis caused by malignant transformation of normal tissues are described. It was also shown that the error-prone DNA synthesis catalyzed by Pol iota in extracts of all cell types was efficiently suppressed by an RNA aptamer (IKL5) against Pol iota obtained in our work earlier. The obtained results suggest that IKL5 might be used to suppress the enhanced activity of Pol iota in tumor cells.


Assuntos
DNA Polimerase Dirigida por DNA/genética , DNA Polimerase Dirigida por DNA/metabolismo , Manganês/farmacologia , Melanoma/enzimologia , Neoplasias Uveais/enzimologia , Animais , Aptâmeros de Nucleotídeos/farmacologia , Linhagem Celular Tumoral/efeitos dos fármacos , Linhagem Celular Tumoral/enzimologia , Transformação Celular Neoplásica/genética , DNA/biossíntese , Relação Dose-Resposta a Droga , Células HL-60/efeitos dos fármacos , Humanos , Melanoma/tratamento farmacológico , Camundongos , Camundongos Endogâmicos C57BL , Neoplasias Uveais/tratamento farmacológico , DNA Polimerase iota
5.
Acta Naturae ; 5(4): 34-43, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24455181

RESUMO

Aptamers are short single-stranded oligonucleotides that are capable of binding various molecules with high affinity and specificity. When the technology of aptamer selection was developed almost a quarter of a century ago, a suggestion was immediately put forward that it might be a revolutionary start into solving many problems associated with diagnostics and the therapy of diseases. However, multiple attempts to use aptamers in practice, although sometimes successful, have been generally much less efficient than had been expected initially. This review is mostly devoted not to the successful use of aptamers but to the problems impeding the widespread application of aptamers in diagnostics and therapy, as well as to approaches that could considerably expand the range of aptamer application.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...